Roche loan in doubt after record bond issues
Roche’s plans for a jumbo loan have been thrown into doubt after the Swiss drugs group issued more than $16bn of bonds in Europe this week, adding to its $16bn trade last week in the US. The bonds mean Roche has less need to tap the bank market to fund its $42bn hostile bid for US peer Genentech.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
